Literature DB >> 16344903

GABAergic neurons innervating the preganglionic cardiac vagal neurons in the dorsal motor nucleus receive tonic glutamatergic control.

Ji-Jiang Wang1, Yong-Hua Chen, Ke-Yong Li, Feng-Yan Sun.   

Abstract

The glutamatergic innervations and the GABAergic innervations are respectively the major excitatory and inhibitory inputs of preganglionic cardiac vagal neurons (CVNs). Whether and how these two kinds of innervations interact in the regulation of CVNs is unknown. Using retrograde fluorescent labeling of CVNs and voltage patch-clamp technique, we demonstrated that mixed global application of glutamatergic NMDA and non-NMDA antagonists AP(5) and CNQX, while had no effect on the GABAergic synaptic events of the CVNs in the nucleus ambiguus (NA), significantly decreased the GABAergic synaptic events of the CVNs in the dorsal motor nucleus of the vagus (DMNX). These results suggest that the GABAergic neurons preceding the CVNs in the DMNX receive tonic glutamatergic control, whereas the GABAergic neurons preceding the CVNs in the NA receive little, if any, glutamatergic innervations. This differential central regulation of the CVNs in the DMNX from those in the NA might be a possible mechanism that enables the CVNs in the DMNX play different roles from those in the NA in the parasympathetic control of heart rate and cardiac functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16344903

Source DB:  PubMed          Journal:  Sheng Li Xue Bao        ISSN: 0371-0874


  2 in total

1.  Chronic intermittent hypoxia and hypercapnia inhibit the hypothalamic paraventricular nucleus neurotransmission to parasympathetic cardiac neurons in the brain stem.

Authors:  Olga Dergacheva; Jhansi Dyavanapalli; Ramón A Piñol; David Mendelowitz
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

2.  Role of ionotropic GABA, glutamate and glycine receptors in the tonic and reflex control of cardiac vagal outflow in the rat.

Authors:  Cara M Hildreth; Ann K Goodchild
Journal:  BMC Neurosci       Date:  2010-10-13       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.